Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes

Open access
Lim, Hyejin, Lim, Yu-Mi, Kim, Kook Hwan, Jeon, Young Eui, Park, Kihyoun, Kim, Jinyoung, Hwang, Hui-Yun, Lee, Dong Jin, Pagire, Haushabhau, Kwon, Ho Jeong, Ahn, Jin Hee, Lee, Myung-Shik · 2018 · Nature Communications

Abstract

Autophagy is a critical regulator of cellular homeostasis, dysregulation of which is associated with diverse diseases. Here we show therapeutic effects of a novel autophagy enhancer identified by high-throughput screening of a chemical library against metabolic syndrome. An autophagy enhancer increases LC3-I to LC3-II conversion without mTOR inhibition. MSL, an autophagy enhancer, activates calcineurin, and induces dephosphorylation/nuclear translocation of transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy gene expression. MSL accelerates intracellular lipid clearance, which is reversed by lalistat 2 or Tfeb knockout. Its administration improves the metabolic profile of ob/ob mice and ameliorates inflammasome activation. A chemically modified MSL with increased microsomal stability improves the glucose profile not only of ob/ob mice but also of mice with diet-induced obesity. Our data indicate that our novel autophagy enhancer could be a new drug candidate for diabetes or metabolic syndrome with lipid overload.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-03939-w

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 161

Metadata

Authors
Lim, H., Lim, Y.-M., Kim, K. H., Jeon, Y. E., Park, K., Kim, J., Hwang, H.-Y., Lee, D. J., Pagire, H., Kwon, H. J., Ahn, J. H., & Lee, M.-S.
Venue
Nature Communications
Published
2018-04-12
Volume
9
Issue
1
Pages
1438-1438
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2798211916
Cited by
161
References
26
FWCI
13.81
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes. https://app.cochat.ai/papers/10.1038/s41467-018-03939-w
The paper
Lim, H., Lim, Y.-M., Kim, K. H., Jeon, Y. E., Park, K., Kim, J., Hwang, H.-Y., Lee, D. J., Pagire, H., Kwon, H. J., Ahn, J. H., & Lee, M.-S. (2018). A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes. Nature Communications. https://doi.org/10.1038/s41467-018-03939-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.